Page 48 - Read Online

Page 12 of 14 Almeida et al. Vessel Plus 2021;5:44 https://dx.doi.org/10.20517/2574-1209.2021.66

13. Jones BE, Yang J, Muthigi A, et al. Gene-specific DNA methylation changes predict remission in patients with ANCA-associated
vasculitis. J Am Soc Nephrol 2017;28:1175-87. DOI PubMed PMC
14. Ciavatta DJ, Yang J, Preston GA, et al. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA
vasculitis. J Clin Invest 2010;120:3209-19. DOI PubMed PMC
15. Nakazawa D, Masuda S, Tomaru U, Ishizu A. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis. Nat Rev
Rheumatol 2019;15:91-101. DOI PubMed
16. Laudien M, Gadola SD, Podschun R, et al. Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener’s
granulomatosis as compared to rheumatoid arthritis and chronic Rhinosinusitis with nasal polyps. Clin Exp Rheumatol 2010;28:51-5.
PubMed
17. Scott J, Hartnett J, Mockler D, Little MA. Environmental risk factors associated with ANCA associated vasculitis: a systematic
mapping review. Autoimmun Rev 2020;19:102660. DOI PubMed
18. Watts RA, Gonzalez-Gay MA, Lane SE, Garcia-Porrua C, Bentham G, Scott DG. Geoepidemiology of systemic vasculitis: comparison
of the incidence in two regions of Europe. Ann Rheum Dis 2001;60:170-2. DOI PubMed PMC
19. Pearce FA, Lanyon PC, Watts RA, Grainge MJ, Abhishek A, Hubbard RB. Novel insights into the aetiology of granulomatosis with
polyangiitis-a case-control study using the Clinical Practice Research Datalink. Rheumatology (Oxford) 2018;57:1002-10. DOI
PubMed PMC
20. Gómez-Puerta JA, Gedmintas L, Costenbader KH. The association between silica exposure and development of ANCA-associated
vasculitis: systematic review and meta-analysis. Autoimmun Rev 2013;12:1129-35. DOI PubMed PMC
21. Lane SE, Watts RA, Bentham G, Innes NJ, Scott DG. Are environmental factors important in primary systemic vasculitis? Arthritis
Rheum 2003;48:814-23. DOI PubMed
22. Stamp LK, Chapman PT, Francis J, et al. Association between environmental exposures and granulomatosis with polyangiitis in
Canterbury, New Zealand. Arthritis Res Ther 2015;17:333. DOI PubMed PMC
23. Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science 2004;303:1532-5. DOI PubMed
24. Sangaletti S, Tripodo C, Chiodoni C, et al. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to
myeloid dendritic cells toward ANCA induction and associated autoimmunity. Blood 2012;120:3007-18. DOI PubMed
25. Hakkim A, Fürnrohr BG, Amann K, et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis.
Proc Natl Acad Sci U S A 2010;107:9813-8. DOI PubMed PMC
26. Nakazawa D, Shida H, Tomaru U, et al. Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA-associated
microscopic polyangiitis. J Am Soc Nephrol 2014;25:990-7. DOI PubMed PMC
27. Hiwa R, Ohmura K, Arase N, et al. Myeloperoxidase/HLA Class II complexes recognized by autoantibodies in microscopic
polyangiitis. Arthritis Rheumatol 2017;69:2069-80. DOI PubMed
28. Leacy E, Brady G, Little MA. Pathogenesis of ANCA-associated vasculitis: an emerging role for immunometabolism. Rheumatology
(Oxford) 2020;59:iii33-41. DOI PubMed
29. Kronbichler A, Lee KH, Denicolò S, et al. Immunopathogenesis of ANCA-associated vasculitis. Int J Mol Sci 2020;21:7319. DOI
PubMed PMC
30. Xiao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC. Alternative complement pathway in the pathogenesis of disease mediated by
anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 2007;170:52-64. DOI PubMed PMC
31. Schreiber A, Xiao H, Jennette JC, Schneider W, Luft FC, Kettritz R. C5a receptor mediates neutrophil activation and ANCA-induced
glomerulonephritis. J Am Soc Nephrol 2009;20:289-98. DOI PubMed PMC
32. Nakazawa D, Shida H, Kusunoki Y, et al. The responses of macrophages in interaction with neutrophils that undergo NETosis. J
Autoimmun 2016;67:19-28. DOI PubMed
33. Chen M, Kallenberg CG. ANCA-associated vasculitides--advances in pathogenesis and treatment. Nat Rev Rheumatol 2010;6:653-64.
DOI PubMed
34. Stegeman C, Tervaert J, de Jong P. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener’s
granulomatosis. Am J Ophthalmol 1996;122:606. DOI PubMed
35. Polzer K, Karonitsch T, Neumann T, et al. Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with
disease activity. Rheumatology (Oxford) 2008;47:804-8. DOI PubMed
36. Csernok E, Hellmich B. Usefulness of vasculitis biomarkers in the era of the personalized medicine. Autoimmun Rev 2020;19:102514.
DOI PubMed
37. Brogan P, Eleftheriou D. Vasculitis update: pathogenesis and biomarkers. Pediatr Nephrol 2018;33:187-98. DOI PubMed PMC
38. Roth AJ, Ooi JD, Hess JJ, et al. Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. J Clin
Invest 2013;123:1773-83. DOI PubMed PMC
39. Lally L, Spiera RF. Biomarkers in ANCA-associated vasculitis. Curr Rheumatol Rep 2013;15:363. DOI PubMed
40. Morris AD, Rowbottom AW, Martin FL, Woywodt A, Dhaygude AP. Biomarkers in ANCA-associated vasculitis: potential pitfalls
and future prospects. Kidney360 2021;2:586-97. DOI
41. Domingues VM, Machado B, Santos J. ANCA-positive vasculitis: clinical implications of ANCA types and titers. Rev Assoc Med Bras
(1992) 2016;62:434-40. DOI PubMed
42. Suwanchote S, Rachayon M, Rodsaward P, et al. Anti-neutrophil cytoplasmic antibodies and their clinical significance. Clin
Rheumatol 2018;37:875-84. DOI PubMed
43. FijoŁek J, Wiatr E. Antineutrophil cytoplasmic antibodies (ANCA) - their role in pathogenesis, diagnosis, and treatment monitoring of
ANCA-associated vasculitis. Cent Eur J Immunol 2020;45:218-27. DOI PubMed PMC